Astrana Health, Inc. (ASTH)
(Delayed Data from NSDQ)
$48.12 USD
+0.19 (0.40%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $48.67 +0.55 (1.14%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Astrana Health, Inc. (ASTH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$58.29 | $67.00 | $45.00 | 21.61% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Astrana Health, Inc. comes to $58.29. The forecasts range from a low of $45.00 to a high of $67.00. The average price target represents an increase of 21.61% from the last closing price of $47.93.
Analyst Price Targets (7 )
Broker Rating
Astrana Health, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, eight are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ASTH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
8/1/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
7/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/11/2024 | Truist Securities | Jailendra Singh | Strong Buy | Strong Buy |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
5/8/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
2/26/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 8 |
Average Target Price | $58.29 |
LT Growth Rate | 20.00% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 60 of 253 |
Current Quarter EPS Est: | 0.36 |